Skip to content

Residual heparinisation after cardiac surgery: A prospective observational study

Residual heparinisation in adult patients after cardiac surgery: A prospective observational study

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ANZCTR
Registry ID
ACTRN12624000796583
Enrollment
100
Registered
2024-06-27
Start date
2024-08-01
Completion date
2024-12-31
Last updated
2024-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

This observational study aims to assess whether a residual heparin effect is contributing to post-operative bleeding in cardiac surgical patients at a single institution. It will also assess whether testing for a residual heparin effect will help in reduce the transfusion of blood components perioperatively. The hypothesis being tested is that a proportion of patients undergoing cardiac surgery are returning to ICU with heparin activity affecting their normal coagulation and that this might result in inappropriate administration of platelets and other blood components.

Interventions

Observational study of adult patients undergoing cardiac surgery. A single blood sample will be drawn from existing arterial cannulae and thromboelastography will be performed at 2-hours following return to ICU to assess for a residual heparin effect. The primary outcome will be to assess for a difference in bleeding, defined by drain tube outputs up to 24 hours post-operatively, identified between patients who do and do not have a residual heparin effect detected. Observational data will be col

Observational study of adult patients undergoing cardiac surgery. A single blood sample will be drawn from existing arterial cannulae and thromboelastography will be performed at 2-hours following return to ICU to assess for a residual heparin effect. The primary outcome will be to assess for a difference in bleeding, defined by drain tube outputs up to 24 hours post-operatively, identified between patients who do and do not have a residual heparin effect detected. Observational data will be collected from arrival in ICU until ICU discharge and will follow routine monitoring of post-cardiac surgical patients. There will be no further participant follow-up.

Sponsors

Liam O'Bryan - St Vincent's Hospital Melbourne
Lead SponsorIndividual

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Adult patients undergoing any elective or emergency cardiac surgery

Exclusion criteria

All cardiac surgical patients eligible

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026